U Pecks1, W Rath2, N Kleine-Eggebrecht3, N Maass2, F Voigt3, T W Goecke3, M G Mohaupt4, G Escher4. 1. Department of Obstetrics and Gynecology, University Hospital of the RWTH, Aachen, Germany; Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. 2. Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. 3. Department of Obstetrics and Gynecology, University Hospital of the RWTH, Aachen, Germany. 4. Department of Nephrology, Hypertension and Clinical Pharmacology and Department of Clinical Research, Inselspital University Hospital Bern, Bern, Switzerland.
Abstract
OBJECTIVE: Lipids and steroid hormones are closely linked. While cholesterol is the substrate for (placental) steroid hormone synthesis, steroid hormones regulate hepatic lipid production. The aim of this study was to quantify circulating steroid hormones and lipid metabolites, and to characterize their interactions in normal and pathological pregnancies with a focus on hepatic and placental pathologies. METHODS: A total of 216 serum samples were analyzed. Group A consisted of 32 patients with uncomplicated pregnancies who were analyzed at three different time-points in pregnancy (from the first through the third trimester) and once post partum. Group B consisted of 36 patients (24th to 42nd week of gestation) with pregnancy pathologies (IUGR n = 10, preeclampsia n = 13, HELLP n = 6, intrahepatic cholestasis n = 7) and 31 controls with uncomplicated pregnancies. Steroid profiles including estradiol, progesterone, and dehydroepiandrosterone were measured by GC-MS and compared with lipid concentrations. RESULTS: In Group A, cholesterol and triglycerides correlated positively with estradiol (cholesterol ρ = 0.50, triglycerides ρ = 0.57) and progesterone (ρ = 0.49, ρ = 0.53) and negatively with dehydroepiandrosterone (ρ = - 0.47, ρ = - 0.38). Smoking during pregnancy affected estradiol concentrations, leading to lower levels in the third trimester compared to non-smoking patients (p < 0.05). In Group B, cholesterol levels were found to be lower in IUGR pregnancies and in patients with HELLP syndrome compared to controls (p < 0.05). Steroid hormone concentrations of estradiol (p < 0.05) and progesterone (p < 0.01) were lower in pregnancies with IUGR. DISCUSSION: Lipid and steroid levels were affected most in IUGR pregnancies, while only minor changes in concentrations were observed for other pregnancy-related disorders. Each of the analyzed entities displayed specific changes. However, since the changes were most obvious in pregnancies complicated by IUGR and only minor changes were observed in pregnancies where patients had impaired liver function, our data suggests that placental rather than maternal hepatic function strongly determines lipid and steroid levels in pregnancy.
OBJECTIVE:Lipids and steroid hormones are closely linked. While cholesterol is the substrate for (placental) steroid hormone synthesis, steroid hormones regulate hepatic lipid production. The aim of this study was to quantify circulating steroid hormones and lipid metabolites, and to characterize their interactions in normal and pathological pregnancies with a focus on hepatic and placental pathologies. METHODS: A total of 216 serum samples were analyzed. Group A consisted of 32 patients with uncomplicated pregnancies who were analyzed at three different time-points in pregnancy (from the first through the third trimester) and once post partum. Group B consisted of 36 patients (24th to 42nd week of gestation) with pregnancy pathologies (IUGR n = 10, preeclampsia n = 13, HELLP n = 6, intrahepatic cholestasis n = 7) and 31 controls with uncomplicated pregnancies. Steroid profiles including estradiol, progesterone, and dehydroepiandrosterone were measured by GC-MS and compared with lipid concentrations. RESULTS: In Group A, cholesterol and triglycerides correlated positively with estradiol (cholesterol ρ = 0.50, triglycerides ρ = 0.57) and progesterone (ρ = 0.49, ρ = 0.53) and negatively with dehydroepiandrosterone (ρ = - 0.47, ρ = - 0.38). Smoking during pregnancy affected estradiol concentrations, leading to lower levels in the third trimester compared to non-smoking patients (p < 0.05). In Group B, cholesterol levels were found to be lower in IUGR pregnancies and in patients with HELLP syndrome compared to controls (p < 0.05). Steroid hormone concentrations of estradiol (p < 0.05) and progesterone (p < 0.01) were lower in pregnancies with IUGR. DISCUSSION: Lipid and steroid levels were affected most in IUGR pregnancies, while only minor changes in concentrations were observed for other pregnancy-related disorders. Each of the analyzed entities displayed specific changes. However, since the changes were most obvious in pregnancies complicated by IUGR and only minor changes were observed in pregnancies where patients had impaired liver function, our data suggests that placental rather than maternal hepatic function strongly determines lipid and steroid levels in pregnancy.
Authors: Toralf Reimer; Henrike Rohrmann; Johannes Stubert; Ulrich Pecks; Michael O Glocker; Dagmar-Ulrike Richter; Bernd Gerber Journal: J Matern Fetal Neonatal Med Date: 2012-10-19
Authors: H G Dörr; A Heller; H T Versmold; W G Sippell; M Herrmann; F Bidlingmaier; D Knorr Journal: J Clin Endocrinol Metab Date: 1989-05 Impact factor: 5.958
Authors: K Winkler; B Wetzka; M M Hoffmann; I Friedrich; M Kinner; M W Baumstark; H Wieland; W März; H P Zahradnik Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958
Authors: Y J Schreuder; B A Hutten; M van Eijsden; E H Jansen; M N Vissers; M T Twickler; T G M Vrijkotte Journal: Eur J Clin Nutr Date: 2011-01-19 Impact factor: 4.016
Authors: Isabelle Vögeli; Hans H Jung; Bernhard Dick; Sandra K Erickson; Robert Escher; John W Funder; Felix J Frey; Geneviève Escher Journal: J Endocrinol Date: 2013-10-04 Impact factor: 4.286
Authors: N Sattar; I A Greer; P J Galloway; C J Packard; J Shepherd; T Kelly; A Mathers Journal: J Clin Endocrinol Metab Date: 1999-01 Impact factor: 5.958
Authors: Stephen Norda; Tanja K Rausch; Thorsten Orlikowsky; Matthias Hütten; Sören Schulz; Wolfgang Göpel; Ulrich Pecks Journal: Biomed Res Int Date: 2017-04-05 Impact factor: 3.411
Authors: Peter J O'Shaughnessy; Jean Philippe Antignac; Bruno Le Bizec; Marie-Line Morvan; Konstantin Svechnikov; Olle Söder; Iuliia Savchuk; Ana Monteiro; Ugo Soffientini; Zoe C Johnston; Michelle Bellingham; Denise Hough; Natasha Walker; Panagiotis Filis; Paul A Fowler Journal: PLoS Biol Date: 2019-02-14 Impact factor: 8.029